-
Loading metrics
Open Access
Peer-reviewed
Research Article
Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms
-
Christopher M. O'Connor ,
* E-mail: christophe.oconnor@duke.edu
Affiliation Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina, United States of America
⨯ -
Mona Fiuzat,
Affiliation Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina, United States of America
⨯ -
Peter E. Carson,
Affiliation Division of Cardiology, Department of Veterans Affairs, Washington, District of Columbia, United States of America
⨯ -
Inder S. Anand,
Affiliation Division of Cardiology, Department of Veterans Affairs, Minneapolis, Minnesota, United States of America
⨯ -
Jonathan F. Plehn,
Affiliation National Heart, Lung, and Blood Institute, National Institutes of Health, Washington, District of Columbia, United States of America
⨯ -
Stephen S. Gottlieb,
Affiliation Department of Medicine, University of Maryland, Baltimore, Maryland, United States of America
⨯ -
Marc A. Silver,
Affiliation Heart and Vascular Institute, Advocate Christ Medical Center, Oak Lawn, Illinois, United States of America
⨯ -
JoAnn Lindenfeld,
Affiliation Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
Alan B. Miller,
Affiliation Division of Cardiology, University of Florida Health Sciences Center, Jacksonville, Florida, United States of America
⨯ -
Michel White,
Affiliation Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
⨯ -
Ryan Walsh,
Affiliation Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
Penny Nelson,
Affiliation Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
Allen Medway,
Affiliation Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
Gordon Davis,
Affiliation ARCA biopharma, Broomfield, Colorado, United States of America
⨯ -
Alastair D. Robertson,
Affiliation Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America
⨯ -
J. David Port,
Affiliations Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America, ARCA biopharma, Broomfield, Colorado, United States of America
⨯ -
James Carr,
Affiliation ARCA biopharma, Broomfield, Colorado, United States of America
⨯ -
Guinevere A. Murphy,
Affiliation ARCA biopharma, Broomfield, Colorado, United States of America
⨯ -
Laura C. Lazzeroni,
Affiliation Department of Psychiatry and Behavioral United States of America, Sciences and of Pediatrics, Stanford University, Stanford, California, United States of America
⨯ -
William T. Abraham,
Affiliation Ohio State University, Columbus, Ohio, United States of America
⨯ -
Stephen B. Liggett,
Affiliation Center for Personalized Medicine and Genomics, University of South Florida, Morsani College of Medicine, Tampa, Florida, United States of America
⨯ - [ ... ],
-
Michael R. Bristow
Affiliations Division of Cardiology/Cardiovascular Institute, University of Colorado School of Medicine, Aurora, Colorado, United States of America, ARCA biopharma, Broomfield, Colorado, United States of America
⨯ - [ view all ]
- [ view less ]
Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms
- Christopher M. O'Connor,
- Mona Fiuzat,
- Peter E. Carson,
- Inder S. Anand,
- Jonathan F. Plehn,
- Stephen S. Gottlieb,
- Marc A. Silver,
- JoAnn Lindenfeld,
- Alan B. Miller,
- Michel White
- Published: October 10, 2012
- https://doi.org/10.1371/journal.pone.0044324